Assay Maturity – Is Your Assay Ready for Microfluidic Commercialisation? -- MEDICA - World Forum for Medicine

20.10.2020

SCHOTT MINIFAB

Assay Maturity – Is Your Assay Ready for Microfluidic Commercialisation?

Are you developing a diagnostic microfluidic product? Validating assay maturity is critical for commercial success.

Assay maturity describes a benchtop assay’s readiness to be translated to microfluidic cartridge format. It is important for assay developers and microfluidic product developers to properly assess this level of maturity prior to launching a product development program. Although almost every new diagnostic product begins with an assay which functions reliably on a benchtop, this alone is not enough to optimally reduce program risks. Setting a new product up for commercial success requires a thorough investigation and understanding of gaps in data along with identification and mitigation of any critical assumptions. That is why SCHOTT MINIFAB’s unique approach to assay translation always starts with a thorough assessment and characterisation of the standard benchtop workflow (benchmark assay). It is this deep insight that drives and supports the subsequent stages of the program and underpins the product’s success.


Exhibitor Data Sheet